Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer

Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.

Solving a breast cancer mystery – why do 'double-positive' women do better? - Cancer Research UK - Cancer News

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer

Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect

The Clinical and Biological Significance of Estrogen Receptor-Low Positive Breast Cancer - Modern Pathology

Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer

Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer

New generation breast cancer cell lines developed from patient-derived xenografts, Breast Cancer Research

Mechanisms of estrogen receptor (ER) actions and endocrine resistance

A: Breast cancer comprises four subtypes defined by the positive (+)